ロード中...
Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review
Epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients. However, these patients inevitably come cross acquired resistance to EGFR-TKIs. The transformation of lung adenocarcinoma to s...
保存先:
| 出版年: | Cancer Biol Ther |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5927699/ https://ncbi.nlm.nih.gov/pubmed/29461911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1435222 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|